The best pain management billing companies in 2026 are the ones solving one specific problem: prior authorization is now denying interventional procedures at rates most practices didn’t budget for. If you bill epidural injections, radiofrequency ablation, or spinal cord stimulator trials, you already know that a missed authorization or a mismatched modifier can turn a $2,000 procedure into a write-off.
Companies like Medical Billers and Coders (MBC), Neolytix, and 5 Star Billing Services all serve this specialty, but they are not interchangeable. Some are built for general practices and treat pain management as one line item among 30 specialties. Others, like MBC, run it as a dedicated coding and authorization workflow.
This guide compares them on the Revenue Cycle Management metrics that actually matter for your revenue, not on marketing claims.
Why Pain Management Billing Broke in 2026
Something changed this year that most practices haven’t fully adjusted to. The CMS Interoperability and Prior Authorization Final Rule (CMS-0057-F) took effect on January 1, 2026, cutting standard PA decision windows from 14 days to 7, and requiring payers to give a specific denial reason instead of a vague “not medically necessary.”
At the same time, CMS launched its WISeR pilot in six states (Arizona, New Jersey, Ohio, Oklahoma, Texas, and Washington), adding prior authorization requirements to Original Medicare for outpatient procedures, including epidural steroid injections and nerve stimulators. Claims filed without authorization in these states now go straight to prepayment review.
Layer on top of that: fluoroscopic guidance (CPT 77003) is now bundled into facet joint codes (64490–64495) and most epidural codes, meaning billing teams still charging it separately are losing revenue without realizing it.
And according to MGMA data, close to 40% of prior authorization requests in pain management now require a peer-to-peer review before approval. This is exactly the environment where choosing among the best pain management billing companies stops being a convenience decision and starts being a revenue decision.
How We Compared These Companies
We didn’t rank on price alone, since pricing in this industry is custom-quoted based on claim volume and complexity anyway. We looked at four things a pain management practice administrator actually cares about:
- Interventional coding depth: does the team understand 62320–62327, 64633–64636, and 63650–63688, or are they generalists applying broad orthopedic logic?
- Prior authorization infrastructure: is PA tracked as a workflow with escalation, or treated as a back-office afterthought?
- Denial rate on pain-specific claims: the industry average sits at 15% to 22% for interventional pain practices, and anything close to single digits is a real differentiator.
- Drug testing and modifier compliance: correct use of presumptive versus definitive urine drug testing codes (G0477–G0483, CPT 80320–80377), and defensible use of modifiers 25, 59, and XU.
Quick Comparison: Best Pain Management Billing Companies 2026
| Company | Best For | Pain Management Denial Rate | PA Workflow Depth | Drug Testing Coding |
| Medical Billers and Coders (MBC) | Interventional & multi-site pain practices | Under 5% | Dedicated escalation team | Full presumptive/definitive coding |
| Neolytix | Small to mid-size pain clinics | 8–12% (specialty avg) | Standard PA tracking | Basic UDT coding |
| 5 Star Billing Services | Practices needing verification-first workflow | Not specialty-published | Intake-stage PA checks | Limited to standard codes |
| Athenahealth | Hospital-affiliated pain programs | ~12% (general, not pain-specific) | Technology-driven, generalist | Not specialty-focused |
| R1 RCM | Hospital-scale pain and anesthesia departments | Varies by contract | Enterprise-level, hospital-centric | Hospital billing model |
| CareCloud | Mid-size multi-specialty groups including pain | ~10% general specialty | Dashboard-based tracking | General, not pain-specific |
#1: Medical Billers and Coders (MBC), Best Overall for Interventional Pain Management
MBC treats pain management as its own specialty center, not a subset of orthopedics or general surgery. That distinction matters because pain management billing has its own denial triggers — bundled fluoroscopy, PA requirements on nearly every interventional code, and heavily audited drug testing categories that generic billing vendors routinely mishandle.
Why MBC leads this comparison:
- Denial rate under 5% across its pain management billing portfolio, against a specialty average of 15% to 22% for interventional practices.
- Named account managers who track denial patterns by procedure category and escalate payer disputes directly, instead of routing everything through a generic support queue.
- Full PA management for epidural steroid injections, facet joint injections, radiofrequency ablation, and spinal cord stimulator trials and implants, the exact procedure set the WISeR pilot now flags for review.
- Correct UDT coding distinguishing presumptive (G0477–G0483, CPT 80300–80304) from definitive testing (CPT 80320–80377), one of the most frequently audited billing categories in the specialty.
- Modifier 25 compliance built into the workflow for E/M visits performed on the same day as a procedure, a common and costly denial trigger when handled inconsistently.
As part of its broader RCM services, MBC also functions as a revenue integrity partner rather than a pass-through claims processor — meaning the reporting shows you where revenue is leaking before it becomes a write-off, not after.
Pricing is structured around claim volume and specialty complexity rather than a flat percentage, and practices comparing vendors can review MBC’s custom-quoted pricing model to see how the structure fits their monthly collections.
Best for: Interventional pain clinics, ambulatory surgical centers running pain procedures, and multi-site groups where denial rates above 15% are already visible in the AR aging report.
#2: Neolytix, Best for Small to Mid-Size Pain Clinics
Neolytix has built a genuinely useful reference library around pain management CPT codes and modifier logic, and its coding compliance team is vocal about the risks of modifiers 59 and XU being applied without chart-level justification. For clinics running a lean back office, this transparency is valuable.
Where Neolytix falls short of the top spot: its PA workflow is standard rather than built specifically around the 2026 CMS timelines, and its denial performance for pain management specifically isn’t published the way MBC’s is. Good fit for smaller practices, less proven at multi-site scale.
#3: 5 Star Billing Services, Best for Verification-First Workflows
5 Star’s model leans heavily on front-end insurance verification, catching eligibility and authorization gaps before the claim is ever filed. That’s a sound philosophy, since most pain management denials trace back to an authorization problem rather than a coding error.
The limitation is depth: their public documentation doesn’t show the same interventional coding specificity or drug testing compliance detail that a high-volume pain practice needs.
#4, #5, #6: Athenahealth, R1 RCM, and CareCloud
These three are credible medical billing services providers, but none of them position pain management as a dedicated specialty line.
Athenahealth’s strength is its payer connectivity and EHR integration for hospital-affiliated programs.
R1 RCM operates at hospital scale and suits large health systems with anesthesia and pain departments bundled into broader RCM contracts.
CareCloud offers solid dashboard visibility for mid-size multi-specialty groups but applies general specialty logic rather than pain-specific protocols.
All three are reasonable choices if pain management is a small percentage of your total claim volume — none of them are built for a practice where interventional procedures are the core of the business.
What to Ask Before You Sign
Not every practice needs the same tier of vendor, but every practice comparing the best pain management billing companies should ask the same questions before signing.
Before comparing quotes, ask every vendor on your shortlist these three questions:
- What is your denial rate specifically for pain management CPT codes, not your overall average?
- How do you track prior authorization status against the new 7-day CMS decision window?
- And do your coders distinguish presumptive from definitive drug testing on every claim, or is that left to the practice?
The answers will tell you more than any sales deck.
Ready to See Where Your Practice Is Losing Revenue?
If your prior authorization denials are climbing, or you simply don’t know your current denial rate on interventional procedures, that gap is worth closing before the WISeR pilot expands further.
MBC’s pain management team, part of its broader medical billing and coding services and Pain Management Billing Services division, will walk through your last 90 days of claims and show you exactly where the leakage is.
Call 888-357-3226 or email info@medicalbillersandcoders.com to get a specialty-specific billing review started this week.
FAQs: Best Pain Management Billing Companies
A strong pain management billing partner shows a documented denial rate specific to interventional procedures, not just a general specialty average, along with a dedicated prior authorization workflow and correct coding for both presumptive and definitive drug testing.
Pricing is custom-quoted based on claim volume, procedure mix, and payer complexity, typically structured as a percentage of collections rather than a flat monthly fee. Most enterprise-grade RCM services avoid publishing a single flat rate because pain management’s procedure mix varies too much practice to practice.
The CMS-0057-F rule and the WISeR pilot in six states have added new authorization checkpoints for procedures like epidural injections and spinal cord stimulators, while fluoroscopy bundling changes have quietly reduced what practices can bill separately, compounding denial risk.
Yes. Definitive drug testing is one of the most frequently audited billing categories in the specialty, and mixing up presumptive versus definitive codes, or exceeding payer frequency limits, is a routine and avoidable denial trigger.
Practices that move to a specialty-dedicated pain management billing team typically see measurable denial rate improvement within one to two billing cycles, since most of the leakage comes from fixable authorization and modifier errors rather than deeper structural issues.

A Subject Matter Expert in healthcare billing operations with nearly 10 years of experience, sharing insights on claims processing, coding support, and revenue cycle optimization. Dedicated to educating healthcare professionals on compliance, accuracy, and strategies to improve billing performance.